TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 52 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $10,013,000 | -8.5% | 9,964,000 | -10.7% | 0.17% | -27.7% |
| Q3 2020 | $10,942,000 | -27.2% | 11,160,000 | -27.4% | 0.24% | -28.7% |
| Q2 2020 | $15,034,000 | +26.5% | 15,366,000 | +20.3% | 0.33% | 0.0% |
| Q1 2020 | $11,883,000 | -4.1% | 12,771,000 | -1.8% | 0.33% | +43.3% |
| Q4 2019 | $12,389,000 | +290.9% | 13,001,000 | +273.6% | 0.23% | +275.8% |
| Q3 2019 | $3,169,000 | -54.1% | 3,480,000 | -53.7% | 0.06% | -51.9% |
| Q2 2019 | $6,907,000 | -46.3% | 7,511,000 | -45.9% | 0.13% | -47.1% |
| Q1 2019 | $12,863,000 | -83.7% | 13,878,000 | -84.0% | 0.24% | -66.0% |
| Q4 2018 | $78,756,000 | +399.8% | 86,786,000 | +418.0% | 0.72% | +238.7% |
| Q3 2018 | $15,756,000 | -3.8% | 16,755,000 | -4.7% | 0.21% | -7.4% |
| Q2 2018 | $16,379,000 | +17.5% | 17,577,000 | +11.1% | 0.23% | +3.6% |
| Q1 2018 | $13,944,000 | +10.5% | 15,820,000 | +10.6% | 0.22% | +11.6% |
| Q4 2017 | $12,624,000 | – | 14,305,000 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Asset Management Company, LLC | 18,321,000 | $16,718,000 | 9.03% |
| INCOME RESEARCH & MANAGEMENT | 15,589,000 | $14,000,000 | 6.80% |
| WHITEBOX ADVISORS LLC | 16,000,000 | $14,487,000 | 0.53% |
| Graham Capital Management, L.P. | 16,525,000 | $15,005,000 | 0.49% |
| ONTARIO TEACHERS PENSION PLAN BOARD | 18,400,000 | $16,752,000 | 0.30% |
| WESTWOOD HOLDINGS GROUP INC | 29,005,000 | $26,516,000 | 0.29% |
| Penn Capital Management Company, LLC | 2,195,000 | $1,987,000 | 0.21% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 10,000,000 | $9,128,000 | 0.17% |
| Polar Capital LLP | 20,663,000 | $18,813,000 | 0.17% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 5,000,000 | $4,529,000 | 0.17% |